PND45 Cost-Utility Analysis of Teriflunomide in Naïve VS. Previously Treated Patients with Relapsing-Remitting Multiple Sclerosis in Italy
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI